Puma Biotechnology (PBYI) Change in Acquisitions & Divestments (2014 - 2026)

Puma Biotechnology (PBYI) has 13 years of Change in Acquisitions & Divestments data on file, last reported at $27.3 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 93.89% year-over-year to $27.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $85.3 million (up 33.11% YoY) and the FY2025 annual result came in at $72.0 million, up 28.96% from the prior year.
• Change in Acquisitions & Divestments grew to $27.3 million in Q1 2026, from $19.9 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $27.3 million in Q1 2026 to a low of -$37000.0 in Q4 2022.
• A 5-year average of $12.0 million and a median of $11.8 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments plunged 100.8% — and 2023, when it soared 8686.49%.
• Tracing PBYI's Change in Acquisitions & Divestments over 5 years: stood at -$37000.0 in 2022, then soared by 8686.49% to $3.2 million in 2023, then soared by 308.25% to $13.0 million in 2024, then soared by 53.62% to $19.9 million in 2025, then soared by 37.21% to $27.3 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $27.3 million (Q1 2026), $19.9 million (Q4 2025), and $27.3 million (Q3 2025), per Business Quant data.